Suzhong Pharmaceutical Group Co., Ltd.
-
Founded in:
1979-11-26 -
Country:
China -
Address:
No. 1 Suzhong Road, Taizhou City, Jiangsu Province -
Tax NO.:
91321200141355745E -
Registered Funds:
160 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 1,2,3,5/4,6-cyclohexane hexane nicotine ester |
It is a mild peripheral vasodilator, which is gradually hydrolyzed into niacin and inositol. It has the pharmacological effects of both niacin and inositol and has a lipid-lowering effect. Its vasodilatory effect is milder and more lasting than that of niacin, and it does not have side effects such as flushing and stomach discomfort after taking niacin. It can selectively dilate blood vessels in diseased areas and sensitive areas stimulated by cold, but has a weaker dilating effect on normal blood vessels. It has the effects of dissolving blood clots, anti-coagulation, anti-fatty liver, and reducing capillary fragility.
More
It is a mild peripheral vasodilator, which is gradually hydrolyzed into niacin and inositol. It has the pharmacological effects of both niacin and inositol and has a lipid-lowering effect. Its vasodilatory effect is milder and more lasting than that of niacin, and it does not have side effects such as flushing and stomach discomfort after taking niacin. It can selectively dilate blood vessels in diseased areas and sensitive areas stimulated by cold, but has a weaker dilating effect on normal blood vessels. It has the effects of dissolving blood clots, anti-coagulation, anti-fatty liver, and reducing capillary fragility. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Zingiberis Rhizoma |
|
0 | ||
| Jujubae Fructus |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 1,10-Phenanthroline hydrate |
|
5144-89-8 | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Versicolor intracellular sugar peptide |
1. Enhance the function of the reticuloendothelial system, improve the function of phagocytes and induce serum interferon concentration; 2. Improve immune function and antagonize cellular immunosuppression caused by chemotherapy drugs; 3. Protect liver damage; 4. Inhibit tumor growth and enhance the effect of anti-cancer drugs; 5. Activate the immune system, have nonspecific anti-infection and anti-shock effects, and reduce the mortality caused by bacterial and viral infections.
More
1. Enhance the function of the reticuloendothelial system, improve the function of phagocytes and induce serum interferon concentration; 2. Improve immune function and antagonize cellular immunosuppression caused by chemotherapy drugs; 3. Protect liver damage; 4. Inhibit tumor growth and enhance the effect of anti-cancer drugs; 5. Activate the immune system, have nonspecific anti-infection and anti-shock effects, and reduce the mortality caused by bacterial and viral infections. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetaminophen |
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect.
More
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect. |
126mg | 103-90-2 | 68 |
| Acetylsalicylic acid |
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect.
More
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect. |
230mg | 50-78-2 | 35 |
| Caffeine |
No specific pharmacological effects were mentioned.
More
No specific pharmacological effects were mentioned. |
30mg | 0 |